Patient-centered Breast Cancer Teleprehabilitation — BC-PREHAB  

Breast Cancer Clinical Trial

Official title: Patient-centered Teleprehabilitation for Women With Breast Cancer: a Feasibility Study

Status Recruiting

Clinical Trial Summary

Surgery, the cornerstone of most cancer treatments, is associated with considerable postoperative complications. Adjusting patients' health behavior before surgery may have beneficial effects on postoperative outcomes.

Women (n=50) who will undergo breast surgery because of stage I-III breast cancer are eligible. All participants will receive multimodal patient-centered teleprehabilitation comprising of motivational interviewing, education, exercise therapy, and stress management.

Clinical Trial Description

Feasibility, participation rate, patient satisfaction, intervention safety, and treatment adherence will be monitored as primary outcomes. Fatigue, pain, quality of life (QoL), physical activity levels, perceived injustice, self-efficacy, and healthcare use are secondary outcomes and will be assessed by self-reported questionnaires at baseline, 0-, 2-, and 6 months post-intervention.

Proof of concept for using telecommunication and exercise therapy in prehabilitation prior to breast cancer surgery is available. We expect the proposed intervention to be feasible and effective at reducing fatigue, pain, perceived injustice, and healthcare use, and at improving treatment adherence, QoL, physical activity levels, and self-efficacy.

Effective prehabilitation interventions can reduce the long-term symptoms that arise/persist beyond treatment completion, improving patients' QoL. By using telecommunication technologies, socio-economic barriers can be reduced, making care accessible to all. ;

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms
• Surgery

• NCT number: NCT05782504
• Study type: Interventional
• Source: Universitair Ziekenhuis Brussel
• Contact: Kenza Mostaqim, Dra.
• Phone: +3224774503
• Email: Kenza.Mostaqim@vub.be
• Status: Recruiting
• Phase: N/A
• Start date: January 30, 2023
• Completion date: August 31, 2024